Market disruption CVS Health is considering a corporate separation and spin-offs; opportunities exist to position automated pharmacy and PBM services to support the new CVS Pharmacy entity post-separation in H1 2028.

Spin-off readiness Upcoming restructuring and potential spin-offs present a window to offer scalable technology and workflow solutions that align with a lean, reorganized retail pharmacy business model.

Cost-control drive The Tennessee ownership law risk highlights a focus on efficiency and compliance; propose cost-reducing digital tools, streamlined procurement, and automation to preserve margins during regulatory changes.

Digital commerce With an emphasis on online prescriptions and wellness product sales, there is a clear opportunity to upsell integration of patient engagement platforms, loyalty programs, and AI-powered search and recommendations.

Executive succession Leadership transitions and new CEO appointments create openings for strategic partnerships around technology modernization, data analytics, and omnichannel capabilities to accelerate post-separation growth.